Julius Clinical
CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read moreCNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read more
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire Speakers: Dr. Sietske Sikkes | Associate Professor a...
On March 14, we presented, in collaboration with ECET, the webinar: The challenges within Epilepsy Trials in Europe During this webinar, guest speakers Prof. Jacqueline French, Prof. Alexis Arzimanoglou and Prof. Eugen Trinka discussed: - E...
We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand. Why? Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientif...
"*" indicates required fields
"*" indicates required fields
